Euclidean Capital LLC
- SEC CIK
- 0001825034
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 11
- +1 vs. Q1 2026
- Portfolio value
- $439.8M
- +$47.5M (+12.1%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Vanguard Ftse All-World Ex-US Index Fund922042775 | ETF | 3,243,484 | $271.6M | 61.8% | 00.0% | Unchanged | – |
| Vanguard Morningstar Value ETF922908744 | ETF | 520,000 | $113.3M | 25.8% | 00.0% | Unchanged | – |
| iShares MSCI India ETF46429B598 | ETF | 369,600 | $18.3M | 4.2% | 00.0% | Unchanged | – |
| ORICOric Pharmaceuticals, Inc. | COM | 989,410 | $10.7M | 2.4% | 00.0% | Unchanged | History |
| TMSTeamshares Inc | COM | 1,099,974 | $9.04M | 2.1% | +1,099,974 | New | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,573,761 | $7.68M | 1.7% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,627,643 | $3.52M | 0.8% | 00.0% | Unchanged | History |
| ALECAlector, Inc. | COM | 1,307,858 | $2.63M | 0.6% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM NEW | 87,696 | $2.28M | 0.5% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 1,015,705 | $750.7K | 0.2% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 170,833 | $2.82K | <0.1% | 00.0% | Unchanged | – |